Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Treatment of Childhood Acute Lymphoblastic Leukemia

This study has been terminated.
(Terminated by IRB for continuing review)
Boston Children’s Hospital
Information provided by:
Dana-Farber Cancer Institute Identifier:
First received: September 9, 2005
Last updated: December 20, 2007
Last verified: December 2007
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2006
  Primary Completion Date: September 2006 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):